Cutaneous mucormycosis following COVID-19 vaccination in a patient with bullous pemphigoid

JAAD Case Rep. 2021 Sep:15:80-81. doi: 10.1016/j.jdcr.2021.06.012. Epub 2021 Jun 26.

Authors

Kishan M Shah¹, Cameron West², Jana Simpson³, Yevgeniya B Rainwater^{1

2}

Affiliations

¹ Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas.
² ProPath, Dermatopathology Division, Dallas, Texas.
³ El Paso Dermatology, El Paso, Texas.

No abstract available

Keywords: COVID-19; bullous pemphigoid; mRNA, messenger RNA; mucormycosis.

Publication types

Case Reports